Bartter syndrome revisited

Journal of Nephrology

Volumn 9, Issue 2, 1996, Pages 81-87

  Schwartz, I David ^a   Alon, Uri S ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Angiotensin II; Bartter syndrome; Chloride; Gitelman syndrome; Hyperprostaglandin E syndrome; Hyperreninemic hyperaldosteronism; Hypertension; Metabolic alkalosis; Potassium; Renal transplant

Indexed keywords

ANGIOTENSIN RECEPTOR;

ARTICLE; BARTTER SYNDROME; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERALDOSTERONISM; HYPERRENINEMIA; HYPOCHLOREMIA; HYPOKALEMIA; METABOLIC ALKALOSIS; PATHOGENESIS; PATHOPHYSIOLOGY;

EID: 0030029814     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. Am J Med 1962; 33: 811-28.
2. Pronove P, MacCardle RC, Bartter FC. Aldosteronism, hypokalemia, and a unique renal lesion in a five year old boy. Acta Endocrinol (Suppl 51) 1960; 167-8.
3. O'Regan S, Rivard GE, Mongeau J-G, Robitaille PO. A circulating inhibitor of platelet aggregation in Bartter's syndrome. Pediatrics 1979; 64: 939-41.
4. Restrepo de Rovetto C, Welch TR, Hug G, Clark KE, Bergstrom W. Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 1989; 115: 397-404.
5. Smilde TJ, Haverman JF, Schipper P, et al. Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J Rheumatol 1994; 21: 1515-9.
6. White CP, Waldron M, Jan JE, Carter JE. Oculocerebral hypopigmentation syndrome associated with Bartter syndrome. Am J Med Genet 1993; 46: 592-6.
7. DeKeyser F, Matthys E, De Paepe A, Verschraegen-Spae MR, Matton M. Trisomy 3 mosaicism in a patient with Bartter syndrome. J Med Genet 1988; 25: 358.
8. Proesmans W, Devlieger H, Van Assche A, et al. Bartter syndrome in two siblings - Antenatal and neonatal observations. Int J Pediatr Nephrol 1985; 6: 63-70.
9. Shalev H, Ohaly M, Meizner I, Carmi R. Prental diagnosis of Bartter syndrome. Prenat Diagn 1994; 14: 996-8.
10. Rudin A. Bartter's syndrome: a review of 28 patients followed for 10 years. Acta Med Scand 1988; 224: 165-71.
11. Trygstad CW, Mangos JA, Bloodworth JMB, Lobeck CC. A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting. Pediatrics 1969; 44: 234-42.
12. Cogan MG, Rector FC Jr. Acid-base disorders. In: Brenner BM, Rector FC Jr, eds. The kidney. 4th ed, Philadelphia: WB Saunders, 1991; 737-804.
13. Sasaki H, Okumura M, Ikeda M, Kawasaki T, Fukiyama K. Hypotensive response to angiotensin II analogue in Bartter's syndrome. New Engl J Med 1976; 294: 611-2.
14. Gordon J, Stokes JB III. Understanding and treating Bartter syndrome. Hosp Pract 1994; 29: 103-10.
15. Yoshida H, Kakuchi J, Yoshikawa N, et al. Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome. Kidney Int 1994; 46: 1505-9.
16. Brimacombe JR, Breen DP. Anesthesia and Bartter's syndrome: a case report and review. J Am Assoc Nurse Anesth 1993; 61: 193-7.
17. Stahl MMS, Vaara I, Hedner P, Ekman R. Vasoactive peptides in Bartter's syndrome. Eur J Clin Invest 1993; 23: 80-3.
18. Fujita T, Sakaguchi H, Shibagaki M, Fukui T, Nomura M, Sekiguchi S. The pathogenesis of Bartter's syndrome: functional and histologic studies. Am J Med 1977; 63: 467-74.
19. Gill JR Jr, Bartter FC. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome. Am J Med 1978; 65: 766-72.
20. Chaimovitz C, Levi J, Better OS, Oslander L, Benderli A. Studies on the site of renal salt loss in a patient with Bartter's syndrome. Pediatr Res 1973; 7: 89-94.
21. Eiam-Ong S, Laski ME, Kurtzman NA. Diseases of renal adenosine triphosphate. Am J Med Sci 1995; 309: 13-25.
22. Boer WH, Hene RJ, Koomans HA, Dorhout Mees EJ. Discrepancy between lithium and free water clearance in patients with Bartter's syndrome. Nephron 1994; 67: 82-7.
23. Takeuchi K, Imai Y, Omata K, et al. A case of secondary aldosteronism similar to Bartter's syndrome with no abnormality in renal chloride reabsorption. Tohoku J Exp Med 1993; 169: 141-57.
24. Stein JH. The pathogenetic spectrum of Bartter's syndrome. Kidney Int 1985; 28: 85-93.
25. Crowe P, Ahmad A, O'Byrne K, Cullen MJ. Bartter's syndrome in two generations of an Irish family. Postgrad Med J 1993; 69: 791-6.
26. Barakat AY, Dabbagh S, de Chadarevian J-P. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and absence of juxtaglomerular apparatus hyperplasia: a variant of Bartter's syndrome or a new syndrome of renal alkalosis. Int J Pediatr Nephrol 1981; 2: 259-61.
27. Rosenblum M, Simpson DP, Evenson M. Factitious Bartter's syndrome. Arch Int Med 1977; 137: 1244-5.
28. Koshida R, Sakazume S, Maruyama H, Okuda N, Ohama K, Asano S. A case of pseudo-Bartter's syndrome due to intestinal malrotation. Acta Paediatr Jpn 1994; 36: 107-11.
29. Grossman H, Duggan E, McCamman S, Welchert E, Hellerstein S. The dietary chloride deficiency syndrome. Pediatrics 1980; 66: 366-74.
30. Cremer W, Bock KD. Syndrome and course of chronic hypokalemic nephropathy in man. Clin Nephrol 1977; 7: 112-9.
31. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966; 79: 221-35.
32. Gitelman HJ, Graham JB, Welt LG. A familial disorder characterized by hypokalemia and hypomagnesemia. Ann NY Acad Sci 1969; 162: 856-64.
33. Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M. Hypomagnesemia of hereditary renal origin. Pediatr Nephrol 1987; 1: 465-72.
34. Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992; 120: 38-43.
35. Stahl MMS, Vaara I. Gitelman versus classic Bartter syndrome. J Pediatr 1993; 123: 671.
36. Bianchetti MG, Bettinelli A, Casez JP, et al. Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman syndrome. J Clin Endocrinol Metab 1995; 80: 224-8.
37. 2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome. Am J Kidney Dis 1995; 25: 824-8.
38. Gitelman HJ. Unresolved issues in the pathogenesis of Bartter's syndrome and its variants. Curr Opin Nephrol Hypertens 1994; 3: 471-4.
39. Marco-Franco JE, Morey A, Ventura C, Gasco JM, Alarcon A. Long-term evolution and growth patterns in a family with Bartter's syndrome. Clin Nephrol 1994; 42: 33-7.
40. Seyherth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Scharer K. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 1985; 107: 694-701.
41. Leonhardt A, Timmermanns G, Roth B, Seyberth HW. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr 1992; 120: 546-54.
42. Shoemaker L, Welch TR, Bergstrom W, Abrams SA, Yergey AL, Vieira N. Calcium kinetics in the hyperprostaglandin E syndrome. Pediatr Res 1993; 33: 92-6.
43. Clive DM. Bartter's syndrome: the unsolved puzzle. Am J Kidney Dis 1995; 25: 813-23.
44. Solomon RJ, Brown RS. Bartter's syndrome: new insights into pathogenesis and treatment. Am J Med 1975; 59: 575-83.
45. Fanconi A, Schachenmann G, Nussli R, Prader A. Chronic hypokalemia with growth retardation, normotensive hyperrenin-hyperaldosterism ("Bartter's syndrome"), and hypercalciuria: report of two cases with emphasis on natural history and on catch-up growth during treatment. Helv Paed Acta 1971; 26: 144-63.
46. Garin EH, Fennell RS III, Iravani A, Richard GA. Treatment of Bartter's syndrome with indomethacin. Am J Dis Child 1980; 134: 258-61.
47. Seidel C, Reinalter S, Seyberth HW, Scharer K. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol 1995; 9: 723-8.
48. Hene RJ, Koomans HA, Boer P, Dorhout Mees EJ. Long-term treatment of Bartter's syndrome with captopril. Br Med J 1982; 285: 695.
49. James JM, Davies D. The use of captopril in Bartter's syndrome. Br Med J 1984; 289: 162.
50. Scherling B, Verder H, Nielson MD, Christensen P, Giese J. Captopril treatment in Bartter's syndrome. Scand J Urol Nephrol 1990; 214: 123-5.
51. Al-Ghamdi SMG, Cameron EC, Sutton RAL. Magnesium deficiency: pathophysiology and clinical overview. Am J Kidney Dis 1994; 24: 737-52.
52. Bettinelli A, Bianchetti MG, Borella P, et al. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalciuria (Gitelman's syndrome). Kidney Int 1995; 47: 547-51.
53. Sano M, Shichiri M, Ida T, Sasaki S, Tsukagoshi H. Pathophysiological role of magnesium in familial Bartter's syndrome. Intern Med 1994; 33: 1-5.
54. Cunningham RJ, Brouhard BH, Berger M, Petrusick T, Travis LB. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome. Pediatrics 1979; 63: 754-6.
55. Pierratos A, Couture RA, Hierlihy PJ, Bell RC, Levine DZ. Bartter's syndrome, nephrocalcinosis and renal insufficiency. Can Med Assoc J 1989; 141: 1055-7.